tiprankstipranks
ValiRx Plc Announces Board Chairman Resignation
Company Announcements

ValiRx Plc Announces Board Chairman Resignation

ValiRx plc (GB:VAL) has released an update.

Don't Miss our Black Friday Offers:

ValiRx Plc, a life science company dedicated to developing early-stage cancer therapeutics and women’s health solutions, has announced the immediate resignation of Kevin Cox as Chairman and Director. The company, which has been listed on the AIM Market of the London Stock Exchange since October 2006, is known for its innovative approach to streamlining drug development processes and bringing novel drug candidates to clinical development and commercialization.

For further insights into GB:VAL stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks UK Auto-Generated NewsdeskValiRx Secures Funding for Prostate Cancer Research
TipRanks UK Auto-Generated NewsdeskValiRx Extends Licensing Option for Cancer Treatment
TipRanks UK Auto-Generated NewsdeskValiRx Subsidiary Secures Key Contract with Amply
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App